Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiovascular Study of Vyvanse in Adults with ADHD
NCT00753012Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Apr 2008
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lisdexamfetamine in attention deficit hyperactivity disorder (ADHD), sponsored by Massachusetts General Hospital. Started Apr 2008; status: completed.
02
Drugs
lisdexamfetamine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00753012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00753012.